Cannabis leaf
Cannabis leaf
Cannabis leaf

CANNABIS

Amidst a complex and rapidly changing regulatory scheme, McMillan’s cannabis industry lawyers are at the leading edge of industry developments. McMillan’s Cannabis Practice Group is one of the largest groups of its kind in Canada. Our specialized team of lawyers works closely with a wide range of industry participants, including licensed producers and retailers. They also work with innovators, investors, technology and other service providers, to help them succeed in the medical cannabis industry.

Among Canada’s top business law firms, McMillan is leading the way in providing innovative and practical solutions to business clients in the evolving cannabis industry. Experts in facilitating business growth, McMillan represented Aurora Cannabis Inc. in its US $2.5 billion (CAD $3.2 billion) acquisition of MedReleaf Corp, the largest M&A deal in the Cannabis sector to date in all of Canada. We also represented iAnthus Capital Holdings Inc. in its $835 million acquisition of MPX Bioceutical Corporation, the first public company-to-public company acquisition involving US cannabis assets.

Our lawyers are experienced professionals with significant in-depth knowledge of the laws, regulations and business landscape of Canada’s medical cannabis industry. Our cannabis industry lawyers provide clients with valuable legal solutions for financing, accessing public markets, licensing and regulation, employment law and workplace issues, mergers and acquisitions, tax structuring and intellectual property matters, whether you are just entering the market or you are already established in the sector.

We help our clients lead by:

  • structuring financing arrangements through private equity, public markets, and venture capital,
  • navigating the complex medical marijuana regulatory system, assisting with regulatory approvals,
  • advising on mergers, acquisitions and divestitures,
  • assisting with labelling, advertising and distribution matters,
  • drafting comprehensive employment agreements and workplace policies in compliance with applicable laws,
  • advising on tax matters, and
  • assisting with patents, trademarks, licensing, outsourcing and strategic alliances

DOWNLOADS

Primary Contacts

View All Contacts

Desmond M. Balakrishnan

Partner, Capital Markets & Securities | Gaming

Georges Dubé

Partner, Capital Markets & Securities

James Munro

Partner, Capital Markets & Securities

News

Insights (10 Posts)View More

Featured Insight

CIRO Proposes Amendments to Strengthen Short Selling Regulations

On January 11, 2024, CIRO proposed amendments aimed at strengthening short selling regulations in Canada.

Read More
Jan 17, 2024
Featured Insight

CSA and CIRO Provide Update on Short Selling Regulatory Regime Review

On November 16, 2023, the CSA and CIRO published CSA/CIRO Staff Notice 23-332 Summary of Comments and Responses to CSA/IIROC Staff Notice 23-329.

Read More
Nov 20, 2023
Featured Insight

Competition Bureau gets into the weeds of the Cannabis Act

The Competition Bureau's submission to support Health Canada's legislative review of the Cannabis Act investigates the competitive dynamics of cannabis industry

Read More
Sep 6, 2023
Featured Insight

Good Smoke? More Guidance on Good Faith from the Ontario Court of Appeal

A recent decision by the Ontario Court of Appeal provides more guidance on good faith.

Read More
Feb 14, 2022
Featured Insight

Has COVID-19 Lit the Fuse on Insolvencies in the Canadian Cannabis Industry?

We look at the recent market analysis of the Canadian cannabis industry and challenges in cannabis restructuring.

Read More
Apr 9, 2020
Featured Insight

CSA Notes Inadequate Disclosure of Financial Interest in Cannabis M&A

Securities regulators provided guidance regarding disclosure of financial interests and conflicts of interest in Cannabis transactions

Read More
Nov 15, 2019
Featured Insight

24-Hour Rule: Court Confirms Limits of Medically Prescribed Cannabis Use in the Workplace

The Supreme Court of Newfoundland and Labrador (“Supreme Court”) has issued an important decision about the limits of accommodating the use of medically prescribed cannabis by an employee working in a safety-sensitive position.

Read More
Jun 24, 2019
Featured Insight

The Next Phase of Canadian Cannabis: What to Expect in 2019 and Beyond

On June 14, 2019, Health Canada unveiled its Final Regulations for New Cannabis Products

Read More
Jun 21, 2019
Featured Insight

First Mover Advantage: The Legalization of Adult Use Cannabis in Canada

Whether you are new to the cannabis industry, interested in starting a cannabis business, or have been seizing opportunities for a while — join us for an interactive day on the strategic and legal implications of the legalization of cannabis in Canada.

Details
October 30, 2018 - 7:30 am to 3:35 pm